Viewing StudyNCT01906385

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 1:48 AM
Last Modification Date: 2024-10-26 @ 11:10 AM
Study NCT ID: NCT01906385
Status: RECRUITING
Last Update Posted: 2024-06-14
First Post: 2012-01-11
Brief Title: Maximum Tolerated Dose Safety and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma ReSPECT
Sponsor: Plus Therapeutics
Organization: Plus Therapeutics
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Glioma
Keywords:
Name View
Grade IV Astrocytoma View
Glioma View
Brain Tumor View
Radiotherapy View
Glioblastoma View
Recurrent Glioblastoma View
Rhenium View
Rhenium Nanoliposome View
Brain Cancer View
GBM View
High Grade Glioma View
Glioblastoma Multiform View